Literature DB >> 218451

Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.

J M Falko, J L Witztum, G Schonfeld, S W Weidman, J B Kolar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 218451     DOI： 10.1016/0002-9343(79)90553-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

1.  Diet and high density lipoproteins.

Authors:  P Oster; G Schlierf; C C Heuck; S Hahn; H Szymanski; B Schellenberg
Journal:  Lipids       Date:  1981-02       Impact factor: 1.880

2.  Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

3.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.

Authors:  M van Dam; M Zwart; F de Beer; A H M Smelt; M H Prins; M D Trip; L M Havekes; P J Lansberg; J J P Kastelein
Journal:  Heart       Date:  2002-09       Impact factor: 5.994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.